Literature DB >> 1153944

Alteration of esophageal peristalsis by pentagastrin in patients with diffuse esophageal spasm.

V F Eckhardt, J Krüger, K H Holtermüller, K Ewe.   

Abstract

Although it has been shown that gastrin and gastric alkalinization affect the lower esophageal sphincter, in vivo studies have not demonstrated a measurable effect of pentagastrin on esophageal peristalsis. In 9 patients with diffuse esophageal spam and in 10 control subjects esophageal peristalsis was recorded before and after pentagastrin infections. Subcutaneous pentagastrin increased peak amplitude significantly more in patients, 31.2 +/- 8.1 mm Hg (mean +/- S.E.M.), than in controls, 12.1 +/- 5.1 mm Hg (P less than 0.02). Max. duration of contraction waves in patients showed a rise of 11.3 +/- 2.7 sec as compared to controls, 1.9 +/- 0.9 sec (P less than 0.01). The effect of pentagastrin on esophageal peristalsis in patients with diffuse esophageal spasm may be explained as denervation supersensitivity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1153944

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Effect of gastrin heptadecapeptide (G17) on oesophageal contractions in patients with diffuse oesophageal spasm.

Authors:  W H Lane; A F Ippoliti; R W McCallum
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

2.  Pentagastrin in diffuse oesophageal spasm.

Authors:  R M Wexler; M D Kaye
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.